Industry & Services >> CEO Interviews >> November 2, 2003
ERIC KRASNOFF is Chairman of the Board and Chief Executive Officer of
Pall Corporation, a leading international manufacturer of sophisticated
filtration, separation and purification products used in the life
sciences and industrial markets. Product applications include blood
banking, biopharmaceutical manufacturing, chemical production,
semiconductor and power generation. Since joining the company in 1975,
Mr. Krasnoff has been a key figure in Pall Corporation's development
into one of the largest industrial companies in the United States. He
has served in a variety of management positions which lead to
responsibility for the company's medical products and diagnostic
business. From 1987 until being elected Pall's President and Chief
Operating Officer in 1993, these products grew from a $40 million
business to $200 million a year. Mr. Krasnoff served as Group Vice
President from 1987 to 1991 and Executive Vice President responsible for
worldwide sales and marketing for all Pall business lines from 1991 to
1993. Mr. Krasnoff was elected Chairman and Chief Executive Officer in
1994. A graduate of Columbia University, Mr. Krasnoff is an active
community leader. He is Chairman of the Board of Trustees of the
National Blood Foundation. He is a Trustee of Long Island University,
serving on its Executive Committee, and is on the President's Advisory
Board of the National Center for Disability Services and is currently
serving as a Vice Chairman of the American Business Conference, among
many eleemosynary involvements. Profile
the past year at Pall that investors should focus on?
Mr. Krasnoff: We made the largest acquisition in our history in
